Switching Sertraline to Duloxetine in Adults
A gradual cross-taper approach is recommended when switching from an SSRI to duloxetine to reduce the risk of SSRI discontinuation symptoms. [1], [2] Duloxetine is labeled to start at 30 mg once daily for 1 week in major depressive disorder before increasing to 60 mg once daily. [2] A clinical trial comparing switch techniques used tapered sertraline discontinuation over 2 weeks with simultaneous duloxetine initiation. [3]
Medication Selection Algorithm
- Continue the antidepressant during a cross-taper rather than abrupt discontinuation when switching from sertraline to duloxetine. [1], [3]
- Initiate duloxetine at the labeled starting dose of 30 mg once daily for 1 week. [2]
Key Evidence Supporting This Recommendation
- In a multicenter trial of switching from an SSRI to duloxetine, a “start-taper switch” used tapered SSRI discontinuation over 2 weeks with simultaneous duloxetine administration. [3]
- Duloxetine labeling supports initiation at 30 mg once daily for 1 week to allow dose adjustment before increasing. [2]
- Sertraline labeling recommends gradual dose reduction rather than abrupt stopping when discontinuing. [1]
Monotherapy Versus Combination Therapy During Transition
- During the transition, short-term overlap of sertraline tapering with duloxetine initiation is used as part of a cross-taper strategy. [3]
- This overlap is not intended as long-term dual antidepressant therapy. [3]
Treatment Initiation Thresholds
- Duloxetine initiation during the switch should use 30 mg once daily as the starting dose for 1 week. [2]
- Sertraline should be reduced gradually during the overlap period rather than stopped abruptly. [1]
Common Pitfalls to Avoid
- Abrupt discontinuation of sertraline should be avoided because gradual reduction is recommended when stopping sertraline. [1]
- Starting duloxetine at higher-than-labeled doses should be avoided in the early switch period because the labeled MDD initiation strategy is 30 mg once daily for 1 week. [2]
- Excessive antidepressant overlap should be avoided beyond the cross-taper window used to transition serotonergic therapy. [3]
Target Goals of Therapy After the Switch
- Duloxetine dose escalation after the initial week should follow labeling to increase toward 60 mg once daily (as tolerated and clinically indicated for the indication being treated). [2]
- Ongoing monitoring for emergent adverse effects and symptom change should occur during both the tapering phase and the early duloxetine dose period. [2]
Example Switching Schedule (Cross-Taper)
- Day 1: Start duloxetine 30 mg once daily. [2]
- Days 1–14: Reduce sertraline gradually rather than stopping abruptly. [1], [3]
- Day 8–14 (after tolerability with the 30 mg start dose): Increase duloxetine toward the labeled target approach after the initial 1-week period if clinically indicated. [2]
- Day 14: Stop sertraline after completion of the taper period used in the start-taper switching strategy. [3]